Cardiovascular clinical trials

Explore recruiting cardiovascular clinical trials.

Recruiting cardiovascular studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Cardiovascular trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Impact of the presence of the corpus luteum on pregnancies obtained through frozen embryo transfer(FET): a prospective randomizedcontrolled study

Spain

Therapeutic use (Phase IV) EU CTIS Study details

VerifyNow to Optimise Platelet Inhibition in Coronary Acute Syndrome (VERONICA)

Spain

Phase III and phase IV (Integrated) EU CTIS Study details

ATLANTIS Protamine - Antagonization of heparin with protamine sulfate to reduce all neurologic ischemic and hemorrhagic events after transcatheter aortic valve implantation for aortic stenosis: the ATLANTIS Protamine study.

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

(21177) A randomized, double-blind, placebo-controlled, parallel-group, multicenter Phase 3 study to investigate the efficacy and safety of Finerenone, in addition to standard of care, on the progression of kidney disease in patients with Non-Diabetic Chronic Kidney Disease

Bulgaria, Denmark, Spain, Czechia, Hungary, Italy +3 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Screening and intervention for subclinical coronary artery disease in patients with type 2 diabetes: THE STENO INTEN-CT STUDY

Denmark

Therapeutic use (Phase IV) EU CTIS Study details

BIOmarker driven intensification of cardiovascular RISK factor management in patients with high risk for recurrent cardiovascular EVENTs

Germany, Poland, Austria

Therapeutic confirmatory (Phase III) EU CTIS Study details

Cardiovascular trials by city

Cardiovascular in Toronto Cardiovascular in Vancouver Cardiovascular in Montreal Cardiovascular in Calgary Cardiovascular in Edmonton Cardiovascular in Ottawa Cardiovascular in Winnipeg Cardiovascular in Quebec City Cardiovascular in Hamilton Cardiovascular in Kitchener Cardiovascular in London Cardiovascular in Halifax Cardiovascular in New York Cardiovascular in Los Angeles Cardiovascular in Chicago Cardiovascular in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease